Skip to content
Fencer Vulns
medium 6.7

CVE-2018-14789 json

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search pa…

published 2018-08-22 8 y ago modified 2026-06-17 4 mo ago also EUVD-2018-6673

cvss
6.7
version 3.1, NVD
cisa kev
Not listed
not in CISA's catalog
epss
0.4%
EPSS 0.4% chance of exploitation in 30 days, percentile 39%
public exploits
0
none known

Summary

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSMA-18-226-01 updated cvss 4.2

Philips IntelliSpace Cardiovascular Vulnerabilities

  • Philips IntelliSpace Cardiovascular <= 3.1 Philips Xcelera <= 4.1
    affected: vendor fix usa.philips.com

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

0.45% chance of exploitation in the next 30 days, higher than 39% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by version score vector
NVD 3.1 6.7 CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
NVD 2.0 4.6 AV:L/AC:L/Au:N/C:P/I:P/A:P

Affected products

  • Philips IntelliSpace Cardiovascular (ISCV) products

Classification

Weakness
  • CWE-428 Unquoted Search Path or Element

References

Sources

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.